Dear Daniela,
Thanks so much for your interest in the ex vivo OT-1 cross-priming assay. In this experiment, we isolated the CD11b−CD11c+ DCs (mostly cDC1), CD11b+CD11c+ DCs, or CD11b+CD11c− F4/80+ TAMs from the irradiated MC38-OVA tumors by cell sorting (BD FACSAria III/Jazz) 5 days after 8 Gy or sham irradiation ± anti-SIRPα and anti–PD-1 (fig. S19). Splenic OT-1 cells were harvested from 6- to 12-week-old C57BL/6-Tg(TcraTcrb)1100Mjb/J mice (#003831) using the CD8α+ T Cell Isolation Kit. The unstimulated OT-1 cells were cocultured with different APC subsets (OT-1:APC = 140,000:70,000) or anti-SIRPα (20 μg/ml) and/or anti–PD-1 (12.5 μg/ml) antibodies alone in RPMI 1640 with 10% FBS and 1% penicillin-streptomycin plus 50 μM β-mercaptoethanol for 48 hours in a 96-well plate. Cells were treated with GolgiPlug 6 hours before intracellular cytokine staining, and the levels of PD-1, CD44, ICOS, Granzyme B, Ki-67, and IFN-γ in OT1 cells were analyzed using flow cytometry. Secreted cytokines in the supernatant were measured using the CBA Mouse Th1/Th2/Th17 Cytokine Kit (BD Biosciences #560485). The protocol of the cytometric bead array can be found on the BD website (https://www.bdbiosciences.com/en-au/products/reagents/immunoassay-reagents/cba/cba-kits/mouse-th1-th2-th17-cba-kit.560485).
Best regards,
Rodney
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.